APO Research
Talk to an analyst

APO RESEARCH · REPORT

Degarelix

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Degarelix Market Outlook and Growth Opportunities 2026

22 December 2025193 pages

Choose your research edition.

Industry ResearchDegarelix Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Degarelix Industry Growth and Trends Forecast to 203263 pages · $3,450 USDMarket StructureGlobal Degarelix Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Degarelix Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Degarelix Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Degarelix market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Degarelix is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Degarelix is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Degarelix is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Degarelix market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Degarelix market include Ferring. among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Degarelix market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Degarelix and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Degarelix revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Degarelix market.

Degarelix Segment by Company

Ferring

Degarelix Segment by Type

120 mg per vial

80 mg per vial

Degarelix Segment by Application

Hospital

Drug store

Degarelix Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Degarelix status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Degarelix key companies, revenue, market share, and recent developments.

3. To split the Degarelix breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Degarelix market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Degarelix significant trends, drivers, influence factors in global and regions.

6. To analyze Degarelix competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Degarelix market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Degarelix and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Degarelix.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Degarelix industry.

Chapter 3: Detailed analysis of Degarelix company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Degarelix in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Degarelix in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Degarelix Industry Trends Table 2. Degarelix Industry Drivers Table 3. Degarelix Industry Opportunities and Challenges Table 4. Degarelix Industry Restraints Table 5. Global Degarelix Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Degarelix Revenue Share by Company (2021-2026) Table 7. Global Degarelix Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Degarelix Key Company Manufacturing Base & Headquarters Table 9. Global Degarelix Company, Product Type & Application Table 10. Global Degarelix Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Degarelix by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of 120 mg per vial Table 15. Significant Companies of 80 mg per vial Table 16. Global Degarelix Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Degarelix Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Degarelix Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Degarelix Sales Value Share by Type (2021-2026) Table 20. Global Degarelix Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Drug store Table 23. Global Degarelix Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Degarelix Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Degarelix Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Degarelix Sales Value Share by Application (2021-2026) Table 27. Global Degarelix Sales Value Share by Application (2027-2032) Table 28. Global Degarelix Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Degarelix Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Degarelix Sales Value Share by Region (2021-2026) Table 31. Global Degarelix Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Degarelix Sales Value Share by Region (2027-2032) Table 33. Global Degarelix Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Degarelix Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Degarelix Sales Value Market Share by Country (2021-2026) Table 36. Global Degarelix Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Degarelix Sales Value Market Share by Country (2027-2032) Table 38. Ferring Company Information Table 39. Ferring Business Overview Table 40. Ferring Degarelix Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Ferring Degarelix Product Portfolio Table 42. Ferring Recent Development Table 43. Research Programs/Design for This Report Table 44. Authors List of This Report Table 45. Secondary Sources Table 46. Primary Sources List of Figures Figure 1. Degarelix Product Image Figure 2. Global Degarelix Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Degarelix Market Size (2021-2032) & (US$ Million) Figure 4. Global Degarelix Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. 120 mg per vial Image Figure 8. 80 mg per vial Image Figure 9. Global Degarelix Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Degarelix Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Degarelix Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Drug store Image Figure 14. Global Degarelix Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Degarelix Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Degarelix Sales Value Share by Application (2021-2032) Figure 17. Global Degarelix Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Degarelix Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Degarelix Sales Value (2021-2032) & (US$ Million) Figure 20. North America Degarelix Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Degarelix Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Degarelix Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Degarelix Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Degarelix Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Degarelix Sales Value (2021-2032) & (US$ Million) Figure 26. South America Degarelix Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Degarelix Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Degarelix Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Degarelix Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Degarelix Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Degarelix Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Degarelix Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Degarelix Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Degarelix Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Degarelix Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Degarelix Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Degarelix Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Degarelix Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Degarelix Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Degarelix Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Degarelix Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Degarelix Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Degarelix Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Degarelix Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Degarelix Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Degarelix Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Degarelix Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Degarelix Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Degarelix Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Degarelix Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Degarelix Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Degarelix Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Degarelix Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Degarelix Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Degarelix Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Degarelix Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Degarelix Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Degarelix Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Degarelix Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Degarelix Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Degarelix Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Degarelix Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Degarelix Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Degarelix Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Degarelix Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Degarelix Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Degarelix Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Degarelix Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Degarelix Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Degarelix Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Degarelix Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Degarelix Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Degarelix Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Degarelix Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Degarelix Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Degarelix Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Degarelix Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Degarelix Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Degarelix Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Degarelix Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Degarelix Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Degarelix Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Degarelix Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Degarelix Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Degarelix Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Degarelix Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Degarelix Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Degarelix Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Degarelix Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Degarelix Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Degarelix Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Degarelix Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Degarelix Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Degarelix Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Degarelix Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Degarelix Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Degarelix Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Degarelix Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Degarelix Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Degarelix Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Degarelix Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Degarelix Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Degarelix Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Degarelix Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Degarelix Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Degarelix Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Degarelix Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Degarelix Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Degarelix Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Degarelix Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Degarelix Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Degarelix Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • 120 mg per vial
  • 80 mg per vial
Applications
  • Hospital
  • Drug store
Companies covered
  • Ferring

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Degarelix Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Degarelix Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Degarelix Market Dynamics
  1. 2.1 Degarelix Industry Trends
  2. 2.2 Degarelix Industry Drivers
  3. 2.3 Degarelix Industry Opportunities and Challenges
  4. 2.4 Degarelix Industry Restraints
3 Degarelix Market by Company
  1. 3.1 Global Degarelix Company Revenue Ranking in 2025
  2. 3.2 Global Degarelix Revenue by Company (2021-2026)
  3. 3.3 Global Degarelix Company Ranking (2024-2026)
  4. 3.4 Global Degarelix Company Manufacturing Base and Headquarters
  5. 3.5 Global Degarelix Company Product Type and Application
  6. 3.6 Global Degarelix Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Degarelix Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Degarelix Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Degarelix Market by Type
  1. 4.1 Degarelix Type Introduction
  2. 4.1.1 120 mg per vial
  3. 4.1.2 80 mg per vial
  4. 4.2 Global Degarelix Sales Value by Type
  5. 4.2.1 Global Degarelix Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Degarelix Sales Value by Type (2021-2032)
  7. 4.2.3 Global Degarelix Sales Value Share by Type (2021-2032)
5 Degarelix Market by Application
  1. 5.1 Degarelix Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drug store
  4. 5.2 Global Degarelix Sales Value by Application
  5. 5.2.1 Global Degarelix Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Degarelix Sales Value by Application (2021-2032)
  7. 5.2.3 Global Degarelix Sales Value Share by Application (2021-2032)
6 Degarelix Regional Value Analysis
  1. 6.1 Global Degarelix Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Degarelix Sales Value by Region (2021-2032)
  3. 6.2.1 Global Degarelix Sales Value by Region: 2021-2026
  4. 6.2.2 Global Degarelix Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Degarelix Sales Value (2021-2032)
  7. 6.3.2 North America Degarelix Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Degarelix Sales Value (2021-2032)
  10. 6.4.2 Europe Degarelix Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Degarelix Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Degarelix Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Degarelix Sales Value (2021-2032)
  16. 6.6.2 South America Degarelix Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Degarelix Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Degarelix Sales Value Share by Country, 2025 VS 2032
7 Degarelix Country-level Value Analysis
  1. 7.1 Global Degarelix Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Degarelix Sales Value by Country (2021-2032)
  3. 7.2.1 Global Degarelix Sales Value by Country (2021-2026)
  4. 7.2.2 Global Degarelix Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Degarelix Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Degarelix Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Degarelix Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Degarelix Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Degarelix Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Degarelix Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Degarelix Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Degarelix Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Degarelix Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Degarelix Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Degarelix Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Degarelix Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Degarelix Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Degarelix Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Degarelix Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Degarelix Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Degarelix Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Degarelix Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Degarelix Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Degarelix Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Degarelix Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Degarelix Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Degarelix Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Degarelix Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Degarelix Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Degarelix Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Degarelix Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Degarelix Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Degarelix Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Degarelix Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Degarelix Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Degarelix Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Degarelix Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Degarelix Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Degarelix Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Degarelix Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Degarelix Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Degarelix Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Degarelix Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Degarelix Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Degarelix Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Degarelix Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Degarelix Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Degarelix Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Degarelix Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Degarelix Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Degarelix Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Degarelix Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Degarelix Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Degarelix Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Degarelix Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Degarelix Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Degarelix Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Degarelix Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Degarelix Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Degarelix Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Degarelix Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Degarelix Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Degarelix Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Degarelix Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Degarelix Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Degarelix Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Degarelix Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Degarelix Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Degarelix Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Degarelix Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Degarelix Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Degarelix Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Degarelix Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Degarelix Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Degarelix Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Degarelix Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Degarelix Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Degarelix Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Degarelix Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Degarelix Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Degarelix Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Degarelix Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Degarelix Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Degarelix Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Degarelix Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Degarelix Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Degarelix Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Degarelix Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Ferring
  2. 8.1.1 Ferring Company Information
  3. 8.1.2 Ferring Business Overview
  4. 8.1.3 Ferring Degarelix Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Ferring Degarelix Product Portfolio
  6. 8.1.5 Ferring Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst